With the popularity of No/Lo Alcohol products gaining even more traction in 2026, why leave compliance as an afterthought when analyzing in-process and final products? R-Biopharm’s Enzytec&tr


With the popularity of No/Lo Alcohol products gaining even more traction in 2026, why leave compliance as an afterthought when analyzing in-process and final products? R-Biopharm’s Enzytec&tr